Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


Articles published in Int J Gynecol Pathol

Retrieve available abstracts of 54 articles:
HTML format
Text format



Single Articles


    November 2018
  1. LEE PJ, McNulty S, Duncavage EJ, Heusel JW, et al
    Clinical Targeted Next-Generation Sequencing Shows Increased Mutational Load in Endometrioid-type Endometrial Adenocarcinoma With Deficient DNA Mismatch Repair.
    Int J Gynecol Pathol. 2018;37:581-589.
    PubMed     Text format     Abstract available


  2. BENNETT JA, Young RH, Chuang AY, Lerwill MF, et al
    Ovarian Metastases of Breast Cancers With Signet Ring Cells: A Report of 17 Cases Including 14 Krukenberg Tumors.
    Int J Gynecol Pathol. 2018;37:507-515.
    PubMed     Text format     Abstract available


  3. HAZAMA Y, Moriya T, Sugihara M, Sano R, et al
    The Analysis of Cell Cycle-related Proteins in Ovarian Clear Cell Carcinoma Versus High-grade Serous Carcinoma.
    Int J Gynecol Pathol. 2018;37:516-524.
    PubMed     Text format     Abstract available


    September 2018
  4. MATRAI CE, Pirog EC, Ellenson LH
    Despite Diagnostic Morphology, Many Mixed Endometrial Carcinomas Show Unexpected Immunohistochemical Staining Patterns.
    Int J Gynecol Pathol. 2018;37:405-413.
    PubMed     Text format     Abstract available


  5. CHAPEL DB, Joseph NM, Krausz T, Lastra RR, et al
    An Ovarian Adenocarcinoma With Combined Low-grade Serous and Mesonephric Morphologies Suggests a Mullerian Origin for Some Mesonephric Carcinomas.
    Int J Gynecol Pathol. 2018;37:448-459.
    PubMed     Text format     Abstract available


  6. AMIT A, Sabo E, Zohar Y, Trugman E, et al
    Evaluation of Microscopic Changes in Fallopian Tubes of BRCA Mutation Carriers by Morphometric Analysis of Histologic Slides: A Preliminary Pilot Study.
    Int J Gynecol Pathol. 2018;37:460-467.
    PubMed     Text format     Abstract available


  7. FANG H, Langstraat CL, Visscher DW, Folpe AL, et al
    Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case.
    Int J Gynecol Pathol. 2018;37:468-472.
    PubMed     Text format     Abstract available


    July 2018
  8. BASSIOUNY D, El-Baz MA, Gamil TM, Shams N, et al
    Endometriosis-associated Ovarian Cancer is a Subset With a More Favorable Outcome and Distinct Clinical-pathologic Characteristics.
    Int J Gynecol Pathol. 2018 Jul 27. doi: 10.1097/PGP.0000000000000533.
    PubMed     Text format     Abstract available


  9. STEWART CJR, Crook ML
    Cerebellar Differentiation in Ovarian Teratoma: A Report of 6 Cases.
    Int J Gynecol Pathol. 2018;37:316-323.
    PubMed     Text format     Abstract available


  10. JU B, Wang J, Yang B, Sun L, et al
    Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2018;37:388-396.
    PubMed     Text format     Abstract available


  11. SINGH N, Benson JL, Gan C, Anglesio M, et al
    Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage.
    Int J Gynecol Pathol. 2018;37:324-330.
    PubMed     Text format     Abstract available


  12. HOLMES M, Robb T
    A Rare Case of Primary Apocrine Adenocarcinoma Arising Within a Mature Cystic Teratoma of the Ovary, Metastatic to a Supraclavicular Lymph Node.
    Int J Gynecol Pathol. 2018;37:344-346.
    PubMed     Text format     Abstract available


  13. BUZA N, Wong S, Hui P
    FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations.
    Int J Gynecol Pathol. 2018;37:305-315.
    PubMed     Text format     Abstract available


  14. HONG S, Cui J, Li L, Buscema J, et al
    Malignant Female Adnexal Tumor of Probable Wolffian Origin: Case Report and Literature Review.
    Int J Gynecol Pathol. 2018;37:331-337.
    PubMed     Text format     Abstract available


  15. SIMONS M, Ebisch I, de Hullu J, van Ham M, et al
    A Patient With a Low-grade Mucinous Neoplasm Involving the Ovary and Pseudomyxoma Peritonei Originating in an Isolated Intestinal Duplication.
    Int J Gynecol Pathol. 2018;37:338-343.
    PubMed     Text format     Abstract available


    May 2018
  16. ONDIC O, Sidlova H, Alaghehbandan R
    Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.
    Int J Gynecol Pathol. 2018 May 10. doi: 10.1097/PGP.0000000000000517.
    PubMed     Text format    


  17. COY S, Meserve E, Berkowitz R, Hirsch MS, et al
    De Novo Tumors of Teratoma: Ganglioneuroma Arising From a Mature Cystic Teratoma of the Ovary.
    Int J Gynecol Pathol. 2018;37:296-300.
    PubMed     Text format     Abstract available


  18. WOLSKY RJ, Price MA, Zaloudek CJ, Rabban JT, et al
    Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
    Int J Gynecol Pathol. 2018;37:262-274.
    PubMed     Text format     Abstract available


  19. TAS EE, Yegin Akcay GF, Yildirim F, Yavuz F, et al
    Coexisting Primary Ovarian and Omental Hydatid Disease Mimicking an Ovarian Neoplasm: A Case Report.
    Int J Gynecol Pathol. 2018;37:301-304.
    PubMed     Text format     Abstract available


  20. RONAGHY A, Xiao GQ, Santagada E, Hasanovic A, et al
    Expression of GATA-3 in Testicular and Gynecologic Mesothelial Neoplastic and Non-neoplastic Tissues.
    Int J Gynecol Pathol. 2018;37:284-289.
    PubMed     Text format     Abstract available


  21. AL-HUSSAINI M, Al-Othman Y, Hijazi E, McCluggage WG, et al
    A Report of Ovarian Sertoli-Leydig Cell Tumors With Heterologous Intestinal-type Glands and Alpha Fetoprotein Elevation and Review of the Literature.
    Int J Gynecol Pathol. 2018;37:275-283.
    PubMed     Text format     Abstract available


  22. VAN ROMPUY AS, Vanderstichele A, Vergote I, Moerman P, et al
    Diffusely Metastasized Adenocarcinoma Arising in a Mucinous Carcinoid of the Ovary: A Case Report.
    Int J Gynecol Pathol. 2018;37:290-295.
    PubMed     Text format     Abstract available


    March 2018
  23. NIU D, Li Z, Sun L, Cao D, et al
    Carcinoid Arising From the Teratomatous Bronchial Mucosa in a Mature Cystic Teratoma of the Ovary: A Case Report.
    Int J Gynecol Pathol. 2018;37:123-127.
    PubMed     Text format     Abstract available


  24. RAWISH KR, Buza N, Zheng W, Fadare O, et al
    Endometrial Carcinoma With Trophoblastic Components: Clinicopathologic Analysis of a Rare Entity.
    Int J Gynecol Pathol. 2018;37:174-190.
    PubMed     Text format     Abstract available


  25. ZADEH SL, Duska LR, Mills AM
    Androgen Receptor Expression in Endometrial Carcinoma.
    Int J Gynecol Pathol. 2018;37:167-173.
    PubMed     Text format     Abstract available


  26. SINGH K, Patel N, Patil P, Paquette C, et al
    Primary Ovarian Solid Pseudopapillary Neoplasm With CTNNB1 c.98C>G (p.S33C) Point Mutation.
    Int J Gynecol Pathol. 2018;37:110-116.
    PubMed     Text format     Abstract available


    January 2018
  27. XING D, Jenson EG, Zwick CA, Rodriguez FJ, et al
    Atypical Proliferative (Borderline) Serous Tumor in the Brain: A Case Report.
    Int J Gynecol Pathol. 2018;37:52-56.
    PubMed     Text format     Abstract available


  28. LONGWORTH A, Ganesan R, Yoong AKH, Hirschowitz L, et al
    Microscopic Heterotopic Extraovarian Sex Cord-Stromal Proliferations: Expanding the Histologic Spectrum.
    Int J Gynecol Pathol. 2018;37:35-43.
    PubMed     Text format     Abstract available


  29. SANCI M, Gungorduk K, Gulseren V, Karadeniz T, et al
    MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrial Cancer.
    Int J Gynecol Pathol. 2018;37:17-21.
    PubMed     Text format     Abstract available


  30. GOLDBERG A, Hand L, DeCotiis D, Rosenblum N, et al
    Microcystic, Elongated, and Fragmented Pattern Invasion in Ovarian Endometrioid Carcinoma: Immunohistochemical Profile and Prognostic Implications.
    Int J Gynecol Pathol. 2018;37:44-51.
    PubMed     Text format     Abstract available


    May 2017
  31. MARTIN DE LA FUENTE L, Malander S, Hartman L, Jonsson JM, et al
    Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.
    Int J Gynecol Pathol. 2017 May 5. doi: 10.1097/PGP.0000000000000394.
    PubMed     Text format     Abstract available


    March 2017
  32. SAID I, Bohm S, Beasley J, Ellery P, et al
    The Chemotherapy Response Score (CRS): Interobserver Reproducibility in a Simple and Prognostically Relevant System for Reporting the Histologic Response to Neoadjuvant Chemotherapy in Tuboovarian High-grade Serous Carcinoma.
    Int J Gynecol Pathol. 2017;36:172-179.
    PubMed     Text format     Abstract available


  33. NEWTON CL, Brockbank E, Singh N, Faruqi A, et al
    A Case of Stage 4B Seromucinous Ovarian Borderline Tumor With Endometriosis and Review of the Literature.
    Int J Gynecol Pathol. 2017;36:195-199.
    PubMed     Text format     Abstract available


  34. HJORTKJAER M, Waldstrom M, Jakobsen A, Kanstrup H, et al
    The Prognostic Value of BRCA1 and PARP Expression in Epithelial Ovarian Carcinoma: Immunohistochemical Detection.
    Int J Gynecol Pathol. 2017;36:180-189.
    PubMed     Text format     Abstract available


  35. CHOUGULE A, Dey P
    Hilus Cell Heterotopia With Intraneural Eutopia.
    Int J Gynecol Pathol. 2017;36:200-202.
    PubMed     Text format    


  36. SANGOI AR, Kshirsagar M, Horvai AE, Roma AA, et al
    SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases.
    Int J Gynecol Pathol. 2017;36:140-145.
    PubMed     Text format     Abstract available


  37. CHEN W, Husain A, Nelson GS, Rambau PF, et al
    Immunohistochemical Profiling of Endometrial Serous Carcinoma.
    Int J Gynecol Pathol. 2017;36:128-139.
    PubMed     Text format     Abstract available


    November 2016
  38. GRAY S, Chen Y, Litton T, Jallad B, et al
    Synchronous Ileal Neuroendocrine Tumor and Ovarian Steroid Cell Tumor Present in a Female With Hyperandrogenism.
    Int J Gynecol Pathol. 2016;35:554-560.
    PubMed     Text format     Abstract available


  39. GOEBEL EA, McCluggage WG, Walsh JC
    Mitotically Active Sclerosing Stromal Tumor of the Ovary: Report of a Case Series With Parallels to Mitotically Active Cellular Fibroma.
    Int J Gynecol Pathol. 2016;35:549-553.
    PubMed     Text format     Abstract available


  40. LIU C, Gallagher RL, Price GR, Bolton E, et al
    Ovarian Microcystic Stromal Tumor: A Rare Clinical Manifestation of Familial Adenomatous Polyposis.
    Int J Gynecol Pathol. 2016;35:561-565.
    PubMed     Text format     Abstract available


  41. MUTUIRI AP, Nzioka A, Busarla SV, Sayed S, et al
    Expression of p53 and HER2/Neu in Kenyan Women With Primary Ovarian Carcinoma.
    Int J Gynecol Pathol. 2016;35:537-543.
    PubMed     Text format     Abstract available


    March 2016
  42. STOLNICU S, Molnar C, Barsan I, Boros M, et al
    The Impact on Survival of an Extensive Sex Cord-like Component in Mullerian Adenosarcomas: A Study Comprising 6 Cases.
    Int J Gynecol Pathol. 2016;35:147-52.
    PubMed     Text format     Abstract available


  43. ARAUJO IB, Pinheiro MV, Zanvettor PH, Studart EJ, et al
    High Frequency of Malignant Transformation of Ovarian Mature Teratoma into Squamous Cell Carcinoma in Young Patients in Northeast Brazil.
    Int J Gynecol Pathol. 2016;35:176-84.
    PubMed     Text format     Abstract available


  44. GOYAL A, Masand RP, Roma AA
    Value of PAX-8 and SF-1 Immunohistochemistry in the Distinction Between Female Adnexal Tumor of Probable Wolffian Origin and its Mimics.
    Int J Gynecol Pathol. 2016;35:167-75.
    PubMed     Text format     Abstract available


  45. STANHISER J, Mahdi H, Rosa G, Harper H, et al
    Prostate-Type Adenocarcinoma in Mature Cystic Ovarian Teratoma.
    Int J Gynecol Pathol. 2016;35:185-90.
    PubMed     Text format     Abstract available


    January 2016
  46. KURMAN RJ, Shih IeM
    Seromucinous Tumors of the Ovary. What's in a Name?
    Int J Gynecol Pathol. 2016;35:78-81.
    PubMed     Text format     Abstract available


  47. WHEELER L, Westhoff GL, O'Keefe MC, Kong CS, et al
    Adenocarcinoma With Breast/Adnexal and Upper Gastrointestinal Differentiation Arising in an Ovarian Mature Cystic Teratoma: A Case Report and Review of the Literature.
    Int J Gynecol Pathol. 2016;35:72-7.
    PubMed     Text format     Abstract available


  48. OHISHI Y, Imamura H, Aman M, Shida K, et al
    Is Invasive Micropapillary Serous Carcinoma a Low-grade Carcinoma?
    Int J Gynecol Pathol. 2016;35:56-65.
    PubMed     Text format     Abstract available


  49. KATO N, Uchigasaki S, Fukase M, Kurose A, et al
    Expression of P450 Aromatase in Granulosa Cell Tumors and Sertoli-Stromal Cell Tumors of the Ovary: Which Cells Are Responsible for Estrogenesis?
    Int J Gynecol Pathol. 2016;35:41-7.
    PubMed     Text format     Abstract available


  50. SUDOUR-BONNANGE H, Rocourt N, Aubry E, Lervat C, et al
    A Sex Cord-stromal Tumor, Specifically a Fibroma, Arising From the Uterine Corpus: A Case Report.
    Int J Gynecol Pathol. 2016;35:33-7.
    PubMed     Text format     Abstract available


  51. HUSSEIN YR, Broaddus R, Weigelt B, Levine DA, et al
    The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
    Int J Gynecol Pathol. 2016;35:16-24.
    PubMed     Text format     Abstract available


  52. HUANG W, Cheng X, Ji J, Zhang J, et al
    The Application Value of HNF-1beta Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2016;35:66-71.
    PubMed     Text format     Abstract available


  53. VANG R, Levine DA, Soslow RA, Zaloudek C, et al
    Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
    Int J Gynecol Pathol. 2016;35:48-55.
    PubMed     Text format     Abstract available


  54. OKOYE EI, Bruegl AS, Fellman B, Luthra R, et al
    Defective DNA Mismatch Repair Influences Expression of Endometrial Carcinoma Biomarkers.
    Int J Gynecol Pathol. 2016;35:8-15.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: